Home Based Infusions for Ocrelizumab

Part of paid clinical trials in Centennial, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT04650321
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • Ocrelizumab at home — DRUG
    Patients will receive ocrelizumab infusion at home.

Study Details

The goal is to assess the safety and effectiveness of home ocrelizumab infusion.

Key Dates

Start date
Mar 1, 2021
Status verified
Jun 2021
Primary completion
Aug 31, 2021
Completion
Aug 31, 2021

Study Design

Enrollment
110 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Home infusion of ocrelizumab
    Patients will receive infusion of ocrelizumab at home, instead of at clinic.

Primary Outcome Measure

Severe infusion reactions [ Time Frame: 24 hours after infusion ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
AmeritaCentennialColorado80112
Kathline Perkins, RN
[email protected]
303-355-4745

Find similar trials in Centennial, CO

By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
Amerita· Centennial, CO

Related Studies